BCAT-IN-4
BCAT-IN-4 (Compound 1) is a BCAT inhibitor. BCAT-IN-4 exhibits a moderate ability to inhibit hBCATc with IC50 value of 2.35 μM. BCAT-IN-4 can be used for the research of neurodegenerative diseases[1].
Product Specifications
CAS Number
406190-85-0
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bcat-in-4.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC2=C(OC3=C2C=CC=C3)C=C1)NNS(=O)(C4=CC=CC=C4)=O
Molecular Formula
C19H14N2O4S
Molecular Weight
366.39
References & Citations
[1]Hu LY, et al. The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases. Bioorg Med Chem Lett. 2006 May 1;16 (9) :2337-40.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS188287-01 0.01 mg
SARS-CoV-2 (2019-nCoV) S protein RBD (K417N, E484K, N501Y), hFc Tag
Sign In for Pricing
View Details MBS188287-02 0.05 mg
SARS-CoV-2 (2019-nCoV) S protein RBD (K417N, E484K, N501Y), hFc Tag
Sign In for Pricing
View Details MBS188287-03 0.1 mg
SARS-CoV-2 (2019-nCoV) S protein RBD (K417N, E484K, N501Y), hFc Tag
Sign In for Pricing
View Details MBS188287-04 5x 0.1 mg
SARS-CoV-2 (2019-nCoV) S protein RBD (K417N, E484K, N501Y), hFc Tag
Sign In for Pricing
View Details 